Biggest News Aggregation in the World
📰 Cute News

Page 80 - Cute News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cute. Real-time updates on events, politics, business and more.

Anebulo Pharmaceuticals : Doses More Than Half of the Subjects in Part A of a Phase 2 Clinical Trial and Provides Guidance on IND Submission - Form 8-K

Anebulo Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse disorder , today... | April 1, 2022
United States Scott Anderson Simon Allen Anebulo Pharmaceuticals Anebulo Pharmaceuticals Inc Company Or Anebulo

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Aptevo Therapeutics Announces Monotherapy Patient Received a Transplant in APVO436 Expansion Trial for the Treatment of Acute Myeloid Leukemia

Patients in Both Monotherapy and Combination Arms in Multi-Cohort Trial Have Achieved Transplant Eligible StatusSEATTLE, WA / ACCESSWIRE / March 29, 2022 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage
United States Miriam Weber Miller Dirk Huebner Justin Watts Exchange Commission American Society Of Hematology

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science